Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check5 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 was added to the site footer, and older notices including 'Revision: v3.4.1' and the funding lapse notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now displays a government funding lapse notice at the top, informing users about potential processing delays and directing to official status sources. The revision tag has changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now includes a 'Show glossary' option and adds the 'Last Update Submitted that Met QC Criteria' metadata with revision 'v3.4.0'. It removes the older 'Last Update Submitted that met QC Criteria' field, the 'No FEAR Act data' item, and the previous revision 'v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedAn administrative revision note was added: Revision: v3.3.4, replacing the previous Revision: v3.3.3. There is no indication that study content, eligibility criteria, or results were changed.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed; the previous Revision: v3.3.2 label is no longer shown.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.